107 related articles for article (PubMed ID: 11863456)
1. Structural requirements for high-affinity heparin binding: alanine scanning analysis of charged residues in the C-terminal domain of human extracellular superoxide dismutase.
Stenlund P; Lindberg MJ; Tibell LA
Biochemistry; 2002 Mar; 41(9):3168-75. PubMed ID: 11863456
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the heparin-binding domain of human extracellular superoxide dismutase.
Tibell LA; Sethson I; Buevich AV
Biochim Biophys Acta; 1997 Jun; 1340(1):21-32. PubMed ID: 9217011
[TBL] [Abstract][Full Text] [Related]
3. The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity.
Sandström J; Carlsson L; Marklund SL; Edlund T
J Biol Chem; 1992 Sep; 267(25):18205-9. PubMed ID: 1517248
[TBL] [Abstract][Full Text] [Related]
4. Characterization of heparin binding of human extracellular superoxide dismutase.
Lookene A; Stenlund P; Tibell LA
Biochemistry; 2000 Jan; 39(1):230-6. PubMed ID: 10625498
[TBL] [Abstract][Full Text] [Related]
5. Determination of the structural role of the N-terminal domain of human extracellular superoxide dismutase by use of protein fusions.
Tibell LA; Skärfstad E; Jonsson BH
Biochim Biophys Acta; 1996 Jan; 1292(1):47-52. PubMed ID: 8547348
[TBL] [Abstract][Full Text] [Related]
6. The heparin binding site of human extracellular-superoxide dismutase.
Adachi T; Kodera T; Ohta H; Hayashi K; Hirano K
Arch Biochem Biophys; 1992 Aug; 297(1):155-61. PubMed ID: 1637178
[TBL] [Abstract][Full Text] [Related]
7. Subunit interaction in extracellular superoxide dismutase: effects of mutations in the N-terminal domain.
Stenlund P; Andersson D; Tibell LA
Protein Sci; 1997 Nov; 6(11):2350-8. PubMed ID: 9385637
[TBL] [Abstract][Full Text] [Related]
8. The high concentration of Arg213-->Gly extracellular superoxide dismutase (EC-SOD) in plasma is caused by a reduction of both heparin and collagen affinities.
Petersen SV; Olsen DA; Kenney JM; Oury TD; Valnickova Z; Thøgersen IB; Crapo JD; Enghild JJ
Biochem J; 2005 Jan; 385(Pt 2):427-32. PubMed ID: 15362977
[TBL] [Abstract][Full Text] [Related]
9. Binding of human extracellular superoxide dismutase C to sulphated glycosaminoglycans.
Karlsson K; Lindahl U; Marklund SL
Biochem J; 1988 Nov; 256(1):29-33. PubMed ID: 3223905
[TBL] [Abstract][Full Text] [Related]
10. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain.
Sandström J; Nilsson P; Karlsson K; Marklund SL
J Biol Chem; 1994 Jul; 269(29):19163-6. PubMed ID: 8034674
[TBL] [Abstract][Full Text] [Related]
11. A site-directed mutant of Cu,Zn-superoxide dismutase modeled after native extracellular superoxide dismutase.
Gao B; Flores SC; McCord JM
Biol Trace Elem Res; 1995; 47(1-3):95-100. PubMed ID: 7779581
[TBL] [Abstract][Full Text] [Related]
12. Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change.
Schedin-Weiss S; Desai UR; Bock SC; Olson ST; Björk I
Biochemistry; 2004 Jan; 43(3):675-83. PubMed ID: 14730971
[TBL] [Abstract][Full Text] [Related]
13. An inter-subunit disulfide bond affects affinity of human lung extracellular superoxide dismutase to heparin.
Ookawara T; Eguchi H; Kizaki T; Nakao C; Sato Y; Imazeki N; Matsubara O; Ohno H; Suzuki K
Free Radic Res; 2003 Aug; 37(8):823-7. PubMed ID: 14567441
[TBL] [Abstract][Full Text] [Related]
14. Interaction of heparin with a synthetic pentadecapeptide from the C-terminal heparin-binding domain of fibronectin.
Hari SP; McAllister H; Chuang WL; Christ MD; Rabenstein DL
Biochemistry; 2000 Apr; 39(13):3763-73. PubMed ID: 10736176
[TBL] [Abstract][Full Text] [Related]
15. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.
Thompson LD; Pantoliano MW; Springer BA
Biochemistry; 1994 Apr; 33(13):3831-40. PubMed ID: 8142385
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic modification of the heparin-binding affinity of extracellular superoxide dismutase.
Karlsson K; Edlund A; Sandström J; Marklund SL
Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):623-6. PubMed ID: 8452552
[TBL] [Abstract][Full Text] [Related]
17. Mutagenesis in four candidate heparin binding regions (residues 279-282, 291-304, 390-393, and 439-448) and identification of residues affecting heparin binding of human lipoprotein lipase.
Ma Y; Henderson HE; Liu MS; Zhang H; Forsythe IJ; Clarke-Lewis I; Hayden MR; Brunzell JD
J Lipid Res; 1994 Nov; 35(11):2049-59. PubMed ID: 7868983
[TBL] [Abstract][Full Text] [Related]
18. Chimeras of human extracellular and intracellular superoxide dismutases. Analysis of structure and function of the individual domains.
Stenlund P; Tibell LA
Protein Eng; 1999 Apr; 12(4):319-25. PubMed ID: 10325402
[TBL] [Abstract][Full Text] [Related]
19. The site of nonenzymic glycation of human extracellular-superoxide dismutase in vitro.
Adachi T; Ohta H; Hayashi K; Hirano K; Marklund SL
Free Radic Biol Med; 1992 Sep; 13(3):205-10. PubMed ID: 1505778
[TBL] [Abstract][Full Text] [Related]
20. An arginine-213 to glycine mutation in human extracellular-superoxide dismutase reduces susceptibility to trypsin-like proteinases.
Adachi T; Morihara N; Yamazaki N; Yamada H; Futenma A; Kato K; Hirano K
J Biochem; 1996 Jul; 120(1):184-8. PubMed ID: 8864862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
